Overview

Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma

Status:
Unknown status

Trial end date:
2010-06-01

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to determine the tolerance and overall survival in patients with stage Ⅲ NPC treated with neoadjuvant chemotherapy and concurrent chemoradiation. Secondary objectives of the study are to evaluate the distant metastases free survival, and disease-free survival of patients with stage Ⅲ treated with this regimen.

Phase:

Phase 2

Details

Lead Sponsor:

Fudan University

Treatments:

Cisplatin
Docetaxel
Fluorouracil